Abstract:To explore effects of DNA damage on cell-cycle progression in p53-deficient tumor cells, synchronized HeLa cells at G1, S and G2/M phases were treated with methyl methanesulfnate (MMS). The results showed that the MMS treatment resulted in the cell-cycle arrest or delay in all 3 phases, while the S-phase cells were the most sensitive to MMS. Further studies demonstrated that ATM-Chk2 and p38 MAPK signaling pathways were activated in all 3 phases when the cells were treated with MMS; whereas Chk1 was activated only in S phase under the drug treatment, indicating that Chk1 specifically participated in S-phase checkpoints. To analyze the role of Chk1 in S-phase checkpoints, we administered a specific Chk1 inhibitor, UCN-01, to the S-phase cells. The results showed that the S-phase cells treated with MMS+UCN-01 could enter aberrant mitosis without finishing DNA replication, indicating that Chk1 mainly functions in the DNA damage checkpoint rather than in the replication checkpoint. In addition, MMS treatment alone inhibited the accumulation of cyclin B1, a key component of M-phase CDK-cyclin complex, in the S-phase cells, whereas the inhibition of Chk1 activation resulted in the accumulation of cyclin B1 in the MMS-treated S-phase cells. This observation further supports the view that DNA-damaged S-phase cells enter abnormal mitosis when Chk1 activation is inhibited. Our results demonstrate that Chk1 is a specific kinase that plays an important role in the MMS-induced S-phase DNA damage checkpoint. As p53 is not involved in this process, Chk1 may be a potential target for p53-deficient tumor therapy.

Chk1 is Required for the Metaphase–anaphase Transition Via Regulating the Expression and Localization of Cdc20 and Mad2

Cdk phosphorylation of Chk1 regulates efficient Chk1 activation and multiple checkpoint proficiency

The DNA Damage Effector Chk1 Kinase Regulates Cdc14B Nucleolar Shuttling During Cell Cycle Progression

Chk1 Regulates the S Phase Checkpoint by Coupling the Physiological Turnover and Ionizing Radiation-Induced Accelerated Proteolysis of Cdc25A.

Implications for Chk1 Regulation: the 1.7 Å Crystal Structure of Human Cell Cycle Checkpoint Kinase Chk1

Mad2 Promotes Cyclin B2 Recruitment to the Kinetochore for Guiding Accurate Mitotic Checkpoint.

Chk1 prevents abnormal mitosis of S-phase HeLa cells containing DNA damage

Cdk-mediated Phosphorylation of Chk1 is Required for Efficient Activation and Full Checkpoint Proficiency in Response to DNA Damage

Chk2 sustains PLK1 activity in mitosis to ensure proper chromosome segregation

ULK1 Phosphorylates Mad1 to Regulate Spindle Assembly Checkpoint

Altered Expression of Chk1 Disrupts Cell Cycle Remodeling at the Midblastula Transition in Xenopus laevis Embryos

Mitotic Kinase CDK1 Cooperates with Polo Kinase to Ensure the Temporal Regulation of Kinetochore Microtubule Dynamics and Spindle Checkpoint (802.14)

Checkpoint kinases are required for oocyte meiotic progression by the maintenance of normal spindle structure and chromosome condensation

Cyclin A/Cdk1 promotes chromosome alignment and timely mitotic progression

Cyclin B1 is Localized to Unattached Kinetochores and Contributes to Efficient Microtubule Attachment and Proper Chromosome Alignment During Mitosis.

Atm-Mediated Mad1 Serine 214 Phosphorylation Regulates Mad1 Dimerization And The Spindle Assembly Checkpoint

Integrated Computational Model of Cell Cycle and Checkpoint Reveals Different Essential Roles of Aurora-A and Plk1 in Mitotic Entry.

Chk2 Regulates Cell Cycle Progression During Mouse Oocyte Maturation and Early Embryo Development.

The Bub1–Plk1 kinase complex promotes spindle checkpoint signalling through Cdc20 phosphorylation

Cross-Talk Between Chk1 And Chk2 In Double-Mutant Thymocytes

Defining pathways of spindle checkpoint silencing: functional redundancy between Cdc20 ubiquitination and p31(comet).